Aimei Health Technology Co., Ltd. AFJK
Nasdaq · XNAS · stock · Blank Checks · IPO 2024-01-22
Chart by TradingView
3/9
Piotroski F — financial health
-4.43
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Operating income | -$835,759 | -$1.1M |
| Net income | $1.1M | $2.6M |
| Operating cash flow | -$565,100 | -$672,289 |
| Total assets | $12.1M | $73.8M |
| Total liabilities | $4.1M | $1.5M |
| Shareholders' equity | -$4.1M | -$1.5M |
| Ratios | ||
| Return on assets | 8.8% | 3.5% |
| Return on equity | -26.1% | -172.8% |
| Current ratio | 0.00 | 0.04 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.43 (distress)
- Working capital / assets -0.278
- Retained earnings / assets -0.335
- EBIT / assets -0.069
- Equity / liabilities -0.999
Sector peers
IX · MUFG · MFG · NMR · UNH · CI · all Finance, Insurance & Real Estate →
Source: SEC EDGAR filings · CIK 0001979005 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.